Entity Common Stock, Shares Outstanding of NovoCure Ltd from Q3 2015 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NovoCure Ltd quarterly Entity Common Stock, Shares Outstanding history and change rate from Q3 2015 to Q3 2025.
  • NovoCure Ltd Entity Common Stock, Shares Outstanding for the quarter ending 24 Oct 2025 was 111,981,981, a 3.5% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

NovoCure Ltd Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 111,981,981 +3,780,547 +3.5% 24 Oct 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 111,799,290 +3,581,800 +3.3% 18 Jul 2025 10-Q 24 Jul 2025 2025 Q2
Q1 2025 111,485,634 +3,874,557 +3.6% 18 Apr 2025 10-Q 24 Apr 2025 2025 Q1
Q3 2024 108,201,434 +1,340,321 +1.3% 25 Oct 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 108,217,490 +1,601,616 +1.5% 19 Jul 2024 10-Q 25 Jul 2024 2024 Q2
Q1 2024 107,611,077 +1,401,826 +1.3% 26 Apr 2024 10-Q 02 May 2024 2024 Q1
Q3 2023 106,861,113 +1,911,031 +1.8% 20 Oct 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 106,615,874 +1,877,293 +1.8% 21 Jul 2023 10-Q 27 Jul 2023 2023 Q2
Q1 2023 106,209,251 +1,623,157 +1.6% 28 Apr 2023 10-Q 04 May 2023 2023 Q1
Q3 2022 104,950,082 +1,130,825 +1.1% 21 Oct 2022 10-Q 27 Oct 2022 2022 Q3
Q2 2022 104,738,581 +1,090,710 +1.1% 22 Jul 2022 10-Q 28 Jul 2022 2022 Q2
Q1 2022 104,586,094 +1,172,727 +1.1% 22 Apr 2022 10-Q 28 Apr 2022 2022 Q1
Q3 2021 103,819,257 +2,022,016 +2% 22 Oct 2021 10-Q 28 Oct 2021 2021 Q3
Q2 2021 103,647,871 +2,556,761 +2.5% 23 Jul 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 103,413,367 +2,973,072 +3% 23 Apr 2021 10-Q 29 Apr 2021 2021 Q1
Q3 2020 101,797,241 +2,828,707 +2.9% 23 Oct 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 101,091,110 +2,914,927 +3% 23 Jul 2020 10-Q/A 02 Oct 2020 2020 Q2
Q1 2020 100,440,295 +4,673,821 +4.9% 23 Apr 2020 10-Q/A 02 Oct 2020 2020 Q1
Q3 2019 98,968,534 +5,954,970 +6.4% 23 Oct 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 98,176,183 +5,273,623 +5.7% 18 Jul 2019 10-Q 25 Jul 2019 2019 Q2
Q1 2019 95,766,474 +5,067,406 +5.6% 25 Apr 2019 10-Q 02 May 2019 2019 Q1
Q3 2018 93,013,564 +3,649,729 +4.1% 18 Oct 2018 10-Q 25 Oct 2018 2018 Q3
Q2 2018 92,902,560 +3,899,985 +4.4% 19 Jul 2018 10-Q 26 Jul 2018 2018 Q2
Q1 2018 90,699,068 +2,549,140 +2.9% 19 Apr 2018 10-Q 26 Apr 2018 2018 Q1
Q3 2017 89,363,835 +2,583,422 +3% 19 Oct 2017 10-Q 26 Oct 2017 2017 Q3
Q2 2017 89,002,575 +3,227,801 +3.8% 20 Jul 2017 10-Q 27 Jul 2017 2017 Q2
Q1 2017 88,149,928 +3,723,208 +4.4% 20 Apr 2017 10-Q 27 Apr 2017 2017 Q1
Q3 2016 86,780,413 +3,161,712 +3.8% 27 Oct 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 85,774,774 26 Jul 2016 10-Q 28 Jul 2016 2016 Q2
Q1 2016 84,426,720 26 Feb 2016 10-K 01 Mar 2016 2015 FY
Q3 2015 83,618,701 22 Oct 2015 10-Q 27 Oct 2015 2015 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.